US Tech 100

19,130.40

0.64%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

XCUR

Exicure (XCUR)

Exicure Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XCUR

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
07/19/2024	4:15PM	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:XCUR	Exicure Inc
06/17/2024	4:27PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:XCUR	Exicure Inc
06/17/2024	4:10PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XCUR	Exicure Inc
06/17/2024	4:01PM	Business Wire	Exicure, Inc. Reports First Quarter 2024 Financial Results	NASDAQ:XCUR	Exicure Inc
06/11/2024	5:18PM	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:XCUR	Exicure Inc
06/11/2024	12:12PM	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:XCUR	Exicure Inc
06/06/2024	4:23PM	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:XCUR	Exicure Inc
06/06/2024	4:18PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XCUR	Exicure Inc
06/06/2024	4:17PM	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:XCUR	Exicure Inc
06/06/2024	4:16PM	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:XCUR	Exicure Inc
06/06/2024	4:01PM	Business Wire	Exicure, Inc. Reports Full Year 2023 Financial Results	NASDAQ:XCUR	Exicure Inc
05/23/2024	4:18PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XCUR	Exicure Inc
05/23/2024	4:01PM	Business Wire	Exicure, Inc. Received Nasdaq Notice of a Delisting Determination	NASDAQ:XCUR	Exicure Inc
05/23/2024	12:45PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XCUR	Exicure Inc
05/16/2024	4:59PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:XCUR	Exicure Inc
05/16/2024	4:50PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XCUR	Exicure Inc
05/16/2024	4:45PM	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:XCUR	Exicure Inc
05/16/2024	4:40PM	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:XCUR	Exicure Inc
05/16/2024	4:08PM	Business Wire	Exicure, Inc. Reports Third Quarter 2023 Financial Results	NASDAQ:XCUR	Exicure Inc
05/15/2024	4:45PM	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:XCUR	Exicure Inc
04/22/2024	4:01PM	Business Wire	Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K	NASDAQ:XCUR	Exicure Inc
03/06/2024	12:15PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XCUR	Exicure Inc
03/04/2024	6:36PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XCUR	Exicure Inc
03/04/2024	5:37PM	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:XCUR	Exicure Inc
02/05/2024	4:16PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XCUR	Exicure Inc
02/05/2024	4:01PM	Business Wire	Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	NASDAQ:XCUR	Exicure Inc
01/16/2024	4:16PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XCUR	Exicure Inc
12/01/2023	6:14PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XCUR	Exicure Inc
12/01/2023	4:21PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XCUR	Exicure Inc
11/28/2023	4:19PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XCUR	Exicure Inc